Nordea Investment Management Buys Stake in Sotera Health

The investment firm adds over 100,000 shares of the medical services company to its portfolio.

Mar. 29, 2026 at 9:10am

Got story updates? Submit your updates here. ›

Nordea Investment Management AB, a major European asset manager, has purchased a new stake in Sotera Health Company (NASDAQ: SHC), acquiring 107,822 shares of the medical device and pharmaceutical services provider in the fourth quarter. The $1.9 million investment adds to Sotera Health's institutional ownership, which now stands at over 91% of the company's stock.

Why it matters

Sotera Health is a leading global provider of sterilization, lab testing, and advisory services for the medical device, pharmaceutical, and consumer products industries. The company's diverse service offerings and blue-chip client base have made it an attractive investment target for institutional investors like Nordea as the healthcare sector continues to see heightened demand.

The details

According to a recent 13F filing with the SEC, Nordea Investment Management AB purchased the new stake in Sotera Health during the fourth quarter of 2025. The investment firm joins other major institutional holders like JPMorgan Chase & Co. and Hudson Bay Capital Management LP, which have also built positions in the company over the past year.

  • Nordea Investment Management AB disclosed the new stake in its Q4 2025 13F filing.
  • The investment firm acquired 107,822 shares of Sotera Health in the fourth quarter.

The players

Nordea Investment Management AB

A major European asset management firm that oversees over $500 billion in client assets.

Sotera Health Company

A global provider of sterilization, lab testing, and advisory services for the medical device, pharmaceutical, and consumer products industries.

Got photos? Submit your photos here. ›

The takeaway

Nordea's investment in Sotera Health reflects the growing institutional interest in the company as a provider of critical services to the healthcare industry. The stake adds to Sotera's already strong institutional ownership, signaling confidence in the firm's long-term growth prospects.